DreamCIS

DreamCIS PEG

The PEG Ratio (Price/Earnings-to-Growth) of DreamCIS (223250.KQ) as of Oct 29, 2026 is 1.14. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.54 — a change of -25.91% (lower).

PEG

1.14

YoY

-25.91%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of DreamCIS is 2025 1.14 . PEG Ratio (Price/Earnings-to-Growth) of DreamCIS was 2024 1.54 . It decreases by -25.91% lower compared to the previous year.

The DreamCIS PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
2.39 KRW
Jan 1, 2019
1.96 KRW
Jan 1, 2020
1.68 KRW
Jan 1, 2021
2.53 KRW
Jan 1, 2022
1.85 KRW
Jan 1, 2023
2.18 KRW
Jan 1, 2024
1.54 KRW
Jan 1, 2025
1.14 KRW
The DreamCIS PEG history
YEARPEGYoY
1.14-25.91%
1.54-29.19%
2.18+17.82%
1.85-26.71%
2.53+50.33%
1.68-14.48%
1.96-17.67%
2.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

PEG Ratio (Price/Earnings-to-Growth) of DreamCIS is 1.14 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of DreamCIS changed from 1.54 to 1.14, representing a -25.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) DreamCIS since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s DreamCIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — DreamCIS

All Key Metrics — DreamCIS